Clinical insights

Key research benefits

A tuftsin-derived peptide approved in Russia since 2009 as a prescription anxiolytic — delivered clinically as a nasal spray.

  • Matched a benzodiazepine (medazepam) for anxiety relief without sedation, tolerance, or dependency risk in a 62-patient trial.
  • ~40% of users were "rapid responders," with symptom improvement within 1–3 days.
  • Raises BDNF and supports memory/focus alongside its calming effect — unlike the grogginess typical of anti-anxiety medication.

Research backing

62-patient Russian clinical trial (vs. medazepam); 20-patient rapid-responder trial; human cytokine-balance study (14-day protocol). Nearly all clinical evidence originates from Russian research institutions.

Research Grade Formula

Selank

Cognitive & Mood Support

Anxiolytic Peptide · 10mg

4.9 (312 reviews)

$140

Express Shipping $20 — Australia only

  • Third-party tested
  • Non-GMO
  • GMP certified
How to use

Follow research handling and reconstitution guidance for this compound. Always use appropriate lab technique and sterile materials.

Research Dosage Protocol
What's inside

This vial contains Selank, a synthetic heptapeptide researched in stress-response and cognitive neuroscience models. Material is lyophilized for precise laboratory reconstitution.

Technical overview

  • Contents: Selank research peptide, 10 mg class vial
  • Class: Synthetic anxiolytic-pathway research peptide
  • Purity: ≥99% with analytical lot documentation
  • Appearance: White freeze-dried powder
  • Reconstitution: Use bacteriostatic water; maintain cold-chain after mixing
  • Intended setting: Controlled research environments only

Reconstitute with bacteriostatic water at room temperature. For laboratory research and educational use only — not for human consumption.

Customer reviews

4.9

Based on 312 reviews